Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Journal of Colorectal Disease
Erschienen in: International Journal of Colorectal Disease 1/2012

01.01.2012 | Review

Botulinum toxin and anal fissure: Efficacy and safety systematic review

verfasst von: Eugenia Yiannakopoulou

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The main purpose of this study was to investigate the efficacy and safety of botulinum toxin in the treatment of anal fissure. An answer was attempted to the following research questions: (i) what is the efficacy of botulinum toxin in healing of anal fissure compared to placebo, (ii) what is the efficacy of botulinum toxin in healing of anal fissure compared to other means of chemical sphincterotomy, (iii) what is the efficacy of botulinum toxin in healing of anal fissure compared to surgical sphincterotomy, (iv) what is the short term safety of botulinum toxin injections and (v) what is the long term safety of botulinum toxin injections.

Methods

Clinical trials investigating the effect of botulinum toxin in the treatment of anal fissure met inclusion criteria. Case reports and case series were also included for the estimation of safety. Meta-analysis was not performed due to clinical heterogeneity.

Results

The comparator could be placebo, nitroglycerin ointment, or lateral internal sphincterotomy, with dosage ranging from 20 IU to 50 IU of botulinum toxin. Fissure healing was the most commonly reported primary endpoint but the time period from botulinum toxin injection to fissure healing ranged from 2 weeks to 4 months. Accordingly, outcome data were also heterogenous.

Conclusions

Botulinum toxin injections should be considered a minimally invasive therapeutic option for the treatment of chronic anal fissure. However, well designed randomized trials are needed for the valid estimation of the efficacy and safety of botulinum toxin in this therapeutic indication.
Literatur
1.
Lund JN, Scholefield JH (1996) Aetiology and treatment of anal fissure. Br J Surg 83:1335–1344PubMedCrossRef
2.
Shao WJ, Li GC, Zhang ZK (2009) Systematic review and meta-analysis of randomized controlled trials comparing botulinum toxin with injection with lateral internal sphincterotomy for chronic anal fissure. Int J Colorectal Dis 24:995–1000PubMedCrossRef
3.
Sajid MS, Vijaynagar B, Desai M, Cheek E, Baig MK (2008) Botulinum toxin vs. glyceryl trinitrate for the medical treatment of chronic anal fissure: a meta-analysis. Colorectal Dis 10:541–546PubMedCrossRef
4.
Sajid MS, Hunte S, Hippolyte S, Kiri VA, Maringe C, Baig MK (2008) Comparison of chemical vs. surgical sphincterotomy using botulinum toxin for the treatment of chronic anal fissure. A meta-analysis. Colorectal Dis 10:547–552PubMedCrossRef
5.
Yiannakopoulou E, Damianou C, Bamia C, Papadopoulos J (2005) Adequacy of safety data reporting in randomized clinical trials comparing coxibs with non-selective NSAIDs. Epitheor Klin Farmakol Farmacokinet 23:42–43
6.
Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A (1998) A comparison of botutinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 338:217–220PubMedCrossRef
7.
Siproudhis L, Sébille V, Pigot F, Hémery P, Juguet F, Bellissant E (2003) Lack of efficacy of botulinum toxin in chronic anal fissure. Aliment Pharmacol Ther 1:515–524CrossRef
8.
Colak T, Ipek T, Kanik A, Aydin S (2002) A randomized trial of botulinum toxine vs. lidocaine pomade for chronic anal fissure. Acta Gastroenterol Belg 65:187–190PubMed
9.
Brisinda G, Cadeddu F, Brandara F, Marniga G, Maria G (2007) Randomized clinical trial comparing botulinum toxin injections with 0.2% nitroglycerin ointment for chronic anal fissure. Br J Surg 94:162–167PubMedCrossRef
10.
Fruehauf H, Fried M, Wegmueller B, Bauerfeind P, Thumshirn M (2006) Efficacy and safety of botulinum toxin injection compared with topical nitroglycerin ointment for the treatment of chronic anal fissure. Am J Gastroenterol 101:2107–2112PubMedCrossRef
11.
Festen S, Gisbetz SS, van Schaagen F, Gerhards MF (2009) Blinded randomised trial of botulinum toxin versus isosorbide dinitrate ointment for treatment of anal fissure. Br J Surg 96:1393–1399PubMedCrossRef
12.
De Nardi P, Ortolano E, Radaelli G, Staudacher C (2006) Comparison of glycerine trinitrate and botulinum toxin—a for the treatment of chronic anal fissure: long term results. Dis Colon Rectum 49:427–432PubMedCrossRef
13.
Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (1999) A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 341:65–69PubMedCrossRef
14.
Suknaic S, Patrlj L, SteresiniA M, Skopljanac Macina A, Erdelez L (2008) Surgical or biological sphincterotomy in the treatment of chronic anal fissure. Acta Med Croatica 62:73–80PubMed
15.
Massoud BW, Mehrdad V, Baharak T, Alireza Z (2005) Botulinum toxin injection versus internal anal sphincterotomy for the treatment of chronic anal fissure. Ann Saudi Med 25:140–142PubMed
16.
Iswariah H, Stephens J, Rieger N, Rodda D, Hewett P (2005) Randomized prospective controlled trial of lateral internal sphincterotomy versus injection of botulinum toxin for the treatment of idiopathic fissure in ano. ANZ J Surg 75:553–555PubMedCrossRef
17.
Arroyo A, Pérez F, Serrano P, Candela F, Lacueva J, Calpena R (2005) Surgical vs. chemical (botulinum toxin) sphinterotomy for chronic anal fissure: long term results of a prospective randomised clinical and manometric study. Am J Surg 189:429–434PubMedCrossRef
18.
Arroyo Sebastián A, Pérez Vicente F, Miranda Tauler E, Sánchez Romero A, Serrano Paz P, Calpena Rico R (2005) Surgical (close lateral internal sphincterotomy) versus chemical (botulinum toxin) sphincterotomy as treatment for chronic anal fissure. Med Clin (Barc) 23:573–575CrossRef
19.
Giral A, Memisoglu K, Gültekin Y et al (2004) Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non randomised controlled trial. BMC Gastroenterol 22:7CrossRef
20.
Mentes BB, Irkörücü O, Akin M, Leventoğlu S, Tatlicioğlu E (2003) Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure. Dis Colon Rectum 46:232–237PubMedCrossRef
21.
Algaithy JK (2008) Botulinum toxin versus surgical sphincterotomy in females with chronic anal fissure. Saudi Med J 29:1260–1263PubMed
22.
Nasr M, Ezat H, Elsebae M (2010) Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a randomized controlled trial. World J Surg 34:2730–2734PubMedCrossRef
23.
Sileri P, Mele A, Stolfi VM et al (2007) Medical and surgical treatment of anal fissure: a prospective study. J Gastrointest Surg 11:1541–1548PubMedCrossRef
24.
Sileri P, Tolfi VM, Ranceschilli L, et al. Conservative and surgical treatment of chronic anal fissure: prospective long term study. J Gastrointest Surg 2010 (in press)
25.
Arroyo A, Pérez-Vicente F, Miranda E, Serrano P, Pérez-Vázquez M, Calpena R (2005) Manometric factors associated with recurrence in botulinum toxin treatment for chronic anal fissure. Gastroenterol Hepatol 28:311–314PubMedCrossRef
26.
Arroyo A, Perez F, Serrano P, Candela F, Calpena R (2005) Long term results of botulinum toxin for the treatment of anal fissure: prospective clinical and manometric study. Int J Colorectal Dis 20:267–271PubMedCrossRef
27.
Jost WH (1997) One hundred cases of anal fissure treated with botulinum toxin. Early and long-term results. Dis Colon Rectum 40:1029–1103PubMedCrossRef
28.
Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (1998) Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens. Ann Surg 228:664–669PubMedCrossRef
29.
Minguez M, Herreros B, Espi A et al (2002) Long term follow up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology 123:112–117PubMedCrossRef
30.
Abd Elhady HM, Othman IH, Hablus MA, Ismail TA, Aboryia MH, Selim MF (2009) Long term prospective randomised clinical and manometric comparison between surgical and chemical sphincterotomy for treatment of chronic anal fissure. S Afr J Surg 47:112–114PubMed
31.
Brisinda G, Maria G, Sganga G, Bentivoglio AR, Albanese A, Castagneto M (2002) Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery 131:179–184PubMedCrossRef
32.
Mínguez M, Melo F, Espí A et al (1999) Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum 42:1016–1021PubMedCrossRef
33.
Brisinda G, Albanese A, Cadeddu F et al (2004) Botulinum neurotoxin to treat chronic anal fissure: results of a randomised “botox” vs. “dysport”controlled trial. Aliment Pharmacol Ther 15:695–701CrossRef
34.
Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A (2000) Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg 179:46–50PubMedCrossRef
35.
Godevenos D, Pikoulis E, Pavlakis E et al (2004) The treatment of chronic anal fissure with botulinum toxin. Acta Chir Belg 104:577–80PubMed
36.
Jones OM, Ramalingam T, Merrie A et al (2006) Randomized clinical trial of botulinum toxin plus glyceryl trinitrate vs. botulinum toxin alone for medically resistant chronic anal fissure: overall poor healing rates. Dis Colon Rectum 49:1574–1580PubMedCrossRef
37.
Charúa Guindic L, Fonseca Muñoz E, Guerra Melgar LR, Avendaño Espinosa O, García Pérez NJ, Charúa Levy E (2007) Treatment of chronic anal fissure with botulinum toxin type A. Rev Gastroenterol Mex 72:22–28PubMed
38.
Witte ME, Klaase JM (2006) Favourable results with local injections of botulinum—a toxin in patients with chronic isosorbide dinitrate ointment-resistant anal fissures. Ned Tijdschr Geneeskd 150:1513–1517PubMed
39.
Radwan MM, Ramdan K, Abu-Azab I, Abu-Zidan FM (2007) Botulinum toxin treatment for anal fissure. Afr Health Sci 7:14–17PubMed
40.
Witte ME, Klaase JM (2007) Botulinum toxin A injection in ISDN-ointment resistant chronic anal fissures. Dig Surg 24:197–201PubMedCrossRef
41.
Jost WH, Schanne S, Mlitz H, Schimrigk K (1995) Perianal thrombosis following injection therapy into the external anal sphincter using botulin toxin [letter]. Dis Colon Rectum 38:781PubMedCrossRef
42.
Tilney HS, Heriot AG, Cripps NP (2001) Complication of botulinum toxin injections for anal fissure. Dis Colon Rectum 44:1721PubMedCrossRef
43.
Brown SR, Matabudul Y, Shorthouse AJ (2006) A second case of long term incontinence following botulinum toxin injection for anal fissure. Colorectal Dis 8:452–453PubMedCrossRef
44.
Mallo-González N, López-Rodríguez R, Fentes DP, Campos-Franco J, Lado FL, Alende-Sixto MR (2008) Fourniere's gangrene after botulinum toxin injection. Scand J Nephrol Urol 42:301–303CrossRef
45.
Yiannakopoulou Ε (2009) Βotulinum toxin safety issues: focus on serious and long term adverse events. Ann Plast Surg 62:E57–E59
46.
47.
Yiannakopoulou Ε (2009) Methodological issues regarding safety evaluation in randomized controlled trials of the effectiveness of antibiotic prophylaxis for the prevention of postoperative wound infection. J Antimicrob Chemother 63:843–845PubMedCrossRef
Metadaten
Titel
Botulinum toxin and anal fissure: Efficacy and safety systematic review
verfasst von
Eugenia Yiannakopoulou
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2012
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-011-1286-5

Weitere Artikel der Ausgabe 1/2012

International Journal of Colorectal Disease 1/2012 Zur Ausgabe

Original Article

Does the outcome of colonic flexure cancers differ from the other colonic sites?

Original Article

Morbidity related to defunctioning ileostomy closure after ileal pouch-anal anastomosis and low colonic anastomosis

Letter to the Editor

Fulminant gangrenous ischemic colitis: is it the solely severe type of ischemic colitis?

Original Article

Focused preoperative patient stoma education, prior to ileostomy formation after anterior resection, contributes to a reduction in delayed discharge within the enhanced recovery programme

Original Article

Laparoscopic-assisted versus open resection of right-sided colonic cancer—a prospective randomized controlled trial

Case Report

Intra-abdominal dilation of artificial bowel sphincter pressure-regulating balloon: a case report

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

10.04.2024 | Narbenhernie | Nachrichten

Deutlich weniger Narbenhernien mit der Small-Bites-Technik
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.